首页> 外国专利> BIOMARKERS FOR EARLY DETERMINATION OF A CRITICAL OR LIFE THREATENING RESPONSE TO ILLNESS AND/OR TREATMENT RESPONSE

BIOMARKERS FOR EARLY DETERMINATION OF A CRITICAL OR LIFE THREATENING RESPONSE TO ILLNESS AND/OR TREATMENT RESPONSE

机译:生物标志物,用于早期确定危及疾病和/或治疗反应的关键或生命的威胁

摘要

The invention relates to the use of novel biomarkers and biomarker combinations having utility in the early determination of an individual's critical and/or life threatening response to illness and/or in predicting outcome of said illness. The measurement of expression levels of the products of the biomarkers and combinations of biomarkers of the invention have utility in making the determination of an individual's critical and/or life threatening response to illness. In some embodiments, the biomarker and biomarker combinations are agnostic and are independent of the pre-identification and/or determination of the cause or nature of the illness. In some embodiments, the biomarkers and biomarker combinations can be utilized to select treatment and/or monitor the effectiveness of treatment interventions for an individual who has a critical illness.
机译:本发明涉及新型生物标志物和生物标志物组合的使用,其在早期确定个人的危重和/或危及疾病的危及威胁和/或预测所述疾病的结果时的危险性和/或预测结果。 本发明的生物标志物产品的表达水平的测量和本发明的生物标志物组合具有效用,以确定个人的危及和/或威胁对疾病的威胁反应。 在一些实施方案中,生物标志物和生物标志物组合是不可知的,并且与预识别和/或测定疾病的原因或性质无关。 在一些实施方案中,生物标志物和生物标志物组合可用于选择治疗和/或监测治疗干预患者的治疗干预措施的治疗干预措施。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号